"Pelvic ultrasound evaluation in transgender male during testosterone therapy" G. Senofonte, E. Marcoccia, C. Boccherini, M. Marasco, A. Perlorca, G. Nigro, A. Giancotti, M. Mosconi, F. Lombardo
Introduction: Gender dysphoria (GD) is characterised by significant distress and/or poor
social functioning due to a non-congruence between an individual’s assigned gender and the
perceived gender identity. In Female to Male subjects, androgen therapy aims to induce
physical changes (such as hair growth, tone voice decrease, fat mass redistribution, breast
volume reduction, etc) and cessation of menses. The latest guidelines (Hembree, 2017)
suggest a higher risk of malignancies (uterus and ovaries) and of endometrial hyperplasia than